Research progress of triple therapy in chronic obstructive pulmonary disease / 中国医师杂志

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is a chronic airway disease, which is mainly characterized by persistent respiratory symptoms and irreversible airflow limitation, with high prevalence and high mortality. Exacerbations of COPD will lead to deterioration of lung function and disease progression, which is the focus of COPD management. Pharmacological therapy for COPD is used to improve symptoms, lung function and health status, prevent and treat exacerbation. Triple inhaled therapy for COPD includes long-acting muscarinic antagonist (LAMA), long-acting β 2-agonist (LABA) and inhaled corticosteroid (ICS). This article will review the research progress of triple inhaled therapy for COPD, and provide a reference for the clinical management of COPD.